Cronus Pharma AnaSed Equine Injection
AnaSed Equine Injection, a sedative for horses, has discoloration.
What happened
Cronus Pharma is recalling AnaSed Equine Injection, xylazine injection, 100 mg/mL, Sedative, 50 mL, for use in horses, due to market complaints pertaining to product discoloration. The recall began September 22, 2026, and was added to the FDA's Enforcement Report on October 7, 2026. The product is manufactured for Cronus Pharma LLC, East Brunswick, NJ 08816, made in India, and 5,819 vials are affected.
Summary by Recall Canary from the FDA notice.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Match the list below, then check the codes the FDA notice also names.
AnaSed Equine Injection, xylazine injection
- NDC
- 69043-043-05
- Lot
- C25110AV1
From the FDA notice
AnaSed Equine Injection, xylazine injection, 100 mg/mL, Sedative, 50 mL, Manufactured for: Cronus Pharma LLC, East Brunswick, NJ 08816, Made in India, NDC 69043-043-05; NADA 140-442; for use in horses.
Details
- Company began the recall
- Event ID
- 99950
- Company
- Cronus Pharma
- Hazard
- Product quality defect
- Quantity recalled
- 5,819 vials
Company began the recall
Added to FDA's Enforcement Report
Listed on Recall Canary
In FDA's weekly enforcement report
